Your browser doesn't support javascript.
loading
Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes.
Martínez-Losada, Carmen; Serrano-López, Juana; Serrano-López, Josefina; Noguera, Nelida I; Garza, Eduardo; Piredda, Liliana; Lavorgna, Serena; Consalvo, María Antonietta Irno; Ottone, Tiziana; Alfonso, Valentina; Peinado, Juan Ramón; Garcia-Ortiz, María Victoria; Morales-Ruiz, Teresa; Jérez, Andrés; Hurtado, Ana María; Montesinos, Pau; Cervera, José; Such, Esperanza; Ibañez, Marian; Sempere, Amparo; Sanz, Miguel Ángel; Lo-Coco, Francesco; Sánchez-García, Joaquín.
Afiliação
  • Martínez-Losada C; Hematology Department, Reina Sofía University Hospital/Maimonides Biomedical Research Institute of Córdoba (IMIBIC)/University of Córdoba, Spain.
  • Serrano-López J; Hematology Department, Reina Sofía University Hospital/Maimonides Biomedical Research Institute of Córdoba (IMIBIC)/University of Córdoba, Spain juanitatolea@yahoo.es.
  • Serrano-López J; Hematology Department, Reina Sofía University Hospital/Maimonides Biomedical Research Institute of Córdoba (IMIBIC)/University of Córdoba, Spain.
  • Noguera NI; Department of Biomedicine and Prevention, "Tor Vergata" University, Rome, Italy.
  • Garza E; Laboratory of Neuro-Oncohematology, Santa Lucia Foundation, Rome, Italy.
  • Piredda L; Laboratorios Dr. Moreira, Monterrey, Mexico.
  • Lavorgna S; Department of Biomedicine and Prevention, "Tor Vergata" University, Rome, Italy.
  • Consalvo MAI; Department of Biomedicine and Prevention, "Tor Vergata" University, Rome, Italy.
  • Ottone T; Department of Biomedicine and Prevention, "Tor Vergata" University, Rome, Italy.
  • Alfonso V; Department of Biomedicine and Prevention, "Tor Vergata" University, Rome, Italy.
  • Peinado JR; Department of Biomedicine and Prevention, "Tor Vergata" University, Rome, Italy.
  • Garcia-Ortiz MV; Medical Sciences Department, Faculty of Medicine/University of Ciudad Real (UCLM), Spain.
  • Morales-Ruiz T; Maimónides Biomedical Research Institute of Córdoba (IMIBIC)/University of Córdoba/Reina Sofia University Hospital, Spain.
  • Jérez A; Maimónides Biomedical Research Institute of Córdoba (IMIBIC)/University of Córdoba/Reina Sofia University Hospital, Spain.
  • Hurtado AM; Hematology Department University Hospital Morales Meseguer-IMIB, Spain.
  • Montesinos P; Hematology Department University Hospital Morales Meseguer-IMIB, Spain.
  • Cervera J; Hematology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
  • Such E; Hematology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
  • Ibañez M; Hematology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
  • Sempere A; Hematology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
  • Sanz MÁ; Hematology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
  • Lo-Coco F; Hematology Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
  • Sánchez-García J; Department of Biomedicine and Prevention, "Tor Vergata" University, Rome, Italy.
Haematologica ; 103(9): e400-e403, 2018 09.
Article em En | MEDLINE | ID: mdl-29622659

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenótipo / Proteínas Nucleares / Leucemia Mieloide Aguda / Evolução Clonal / Mutação Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenótipo / Proteínas Nucleares / Leucemia Mieloide Aguda / Evolução Clonal / Mutação Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha